JOURNAL OF MOLECULAR MEDICINE-JMM

简称 J MOL MED ·GERMANY ·出版周期 Monthly ·年均收录 111 篇

4.2

最新影响因子

1.20%

自引率

约25%

投稿难度

平均1.3月

审稿周期

期刊简介

JOURNAL OF MOLECULAR MEDICINE-JMM是一本国际学术期刊，ISSN号为0946-2716，由德国Springer出版社出版，出版地为德国，出版周期为月刊。该期刊的影响因子根据最新数据在3-4之间，属于SCI收录期刊，中科院分区通常位于医学或生物学领域的3区或4区，具体分区需参考当年中科院发布的期刊分区表。期刊并非完全开放获取（OA），但可能提供部分OA选项。JMM主要关注分子医学领域的研究，发文特点包括基础与临床结合的分子机制研究，涉及疾病发病机制、分子诊断、治疗靶点等方向，尤其关注心血管疾病、癌症、神经退行性疾病等重大疾病的分子水平研究。期刊质量中等偏上，适合发表具有创新性的分子医学研究成果，但竞争相对激烈，审稿周期可能较长。风险方面需注意其影响因子波动较小，但近年竞争加剧可能导致录用难度上升，投稿前建议仔细阅读期刊指南以确保研究内容与范围匹配。

影响因子趋势

近期发表

MicroRNA-122 as a regulator and biomarker of liver disease 2026-09-19

METTL3 mitigates age-related hearing loss by inhibiting NF-κB-mediated inflammatory responses through the m6A modification of NFKBIA 2026-09-18

Prospective associations of premature senescence, inflammation, and MERCSs in the cardioprotective effect of CBD in HFpEF 2026-09-18

Regulation of pancreatic beta-cell mass and its importance for antidiabetic therapies 2026-09-18

Correction to: Suppression of OTUD4 protects against myocardialischemia‑reperfusion injury by increasing autophagic fluxand inhibiting apoptosis in cardiomyocytes 2026-09-16

Anti-hyperuricemia therapy alleviates diet-induced gut inflammation via AhR-IL-22-signalling 2026-09-04

Neutrophil extracellular traps in tumor progression: from mechanistic insights and regulatory factors to clinical detection and diagnosis 2026-09-01

L-ICON3 Suppresses Endometriosis in a Murine Model 2026-08-27

SREBF2 promotes mitophagy and protects against ferroptosis via Cav-1-regulated PINK1/Parkin signaling in ischemic heart failure 2026-08-27

The dual roles of lysine-specific demethylase 1 (KDM1A/LSD1) in the modulation of tumor immune microenvironment and its inhibitors in colorectal cancer 2026-08-24